POLAND RESEARCH AND DEVELOPMENT INCENTIVES	3 Months Ended
Mar. 31, 2026
Government Assistance [Abstract]
POLAND RESEARCH AND DEVELOPMENT INCENTIVES	POLAND RESEARCH AND DEVELOPMENT INCENTIVES The Company is eligible for research and development (“R&D”) tax relief in Poland which allows the Company to reduce its tax base through bonus deductions for specific costs, such as salaries and social security contributions for employees working on R&D projects. The Company is able to utilize the tax relief by first offsetting its corporate income tax liability and then, to the extent the tax relief exceeds its corporate income tax liability, reducing future remittances of personal income tax withholding for qualified employees. During the three months ended March 31, 2026, the Company recognized benefits of $12.2 million related to R&D activities completed in Poland which were recorded as a reduction to cost of revenues in the condensed consolidated statement of income. During the three months ended March 31, 2025, the Company recognized benefits of $12.1 million related to R&D activities completed in Poland which were recorded as a reduction to cost of revenues in the condensed consolidated statement of income. As of March 31, 2026, $16.1 million of benefits were included in prepaid and other current assets and $84.7 million of benefits were included in other noncurrent assets on the condensed consolidated balance sheet related to the Poland R&D incentive. As of December 31, 2025, $21.6 million of benefits were included in prepaid and other current assets and $75.3 million of benefits were included in other noncurrent assets on the condensed consolidated balance sheet related to the Poland R&D incentive.

POLAND RESEARCH AND DEVELOPMENT INCENTIVES

3 Months Ended

Mar. 31, 2026

POLAND RESEARCH AND DEVELOPMENT INCENTIVES

The Company is eligible for research and development (“R&D”) tax relief in Poland which allows the Company to reduce its tax base through bonus deductions for specific costs, such as salaries and social security contributions for employees working on R&D projects. The Company is able to utilize the tax relief by first offsetting its corporate income tax liability and then, to the extent the tax relief exceeds its corporate income tax liability, reducing future remittances of personal income tax withholding for qualified employees.

During the three months ended March 31, 2026, the Company recognized benefits of $12.2 million related to R&D activities completed in Poland which were recorded as a reduction to cost of revenues in the condensed consolidated statement of income. During the three months ended March 31, 2025, the Company recognized benefits of $12.1 million related to R&D activities completed in Poland which were recorded as a reduction to cost of revenues in the condensed consolidated statement of income. As of March 31, 2026, $16.1 million of benefits were included in prepaid and other current assets and $84.7 million of benefits were included in other noncurrent assets on the condensed consolidated balance sheet related to the Poland R&D incentive. As of December 31, 2025, $21.6 million of benefits were included in prepaid and other current assets and $75.3 million of benefits were included in other noncurrent assets on the condensed consolidated balance sheet related to the Poland R&D incentive.